Review of the effects of manufactured nanoparticles on mammalian target organs

Journal of Applied Toxicology - Tập 38 Số 1 - Trang 25-40 - 2018
Tianshu Wu1,2,3, Meng Tang1,2,3
1Jiangsu Key Laboratory for Biomaterials and Devices, Southeast University, Nanjing 210009, China
2Key Laboratory of Environmental Medicine and Engineering, Ministry of Education
3Key Laboratory of Environmental Medicine and Engineering, Ministry of Education; School of Public Health, & Collaborative Innovation Center of Suzhou Nano Science and Technology Southeast University Nanjing 210009 China

Tóm tắt

Abstract

Nanotechnology had matured significantly during the last two decades as it has transitioned from bench top science to applied technology. Even though the issue of safety of nanotechnology has been raised nearly one decade ago, the rapid progress in development and use of nanomaterials has not yet been matched by toxicological investigations. Many recent studies have simply outlined the toxic effects of nanoparticles (NPs), but few have systematically addressed their potentially adverse biological effects on target organs. Some animal models have shown that NPs could be accumulated in various organs. These accumulations can access the vasculature and target other organs, resulting in a potential health risks. After the brief description of current knowledge on the wide applications of several common NPs, their applications and the toxicokinetics, this review focused on effects of NPs on organ functions and mammal health after acute or chronic exposure, and potential mechanisms of action. Due to their physical properties, the liver, kidneys and lung are the main target organs of NPs. Most of NPs show slight toxicity when exposed to animals, while certain toxic effects like oxidative stress generation, inflammation and DNA damage are commonly observed. The severity of NPs toxicity is dependent upon several factors, including exposure dose and administration, NPs chemistry, size, shape, agglomeration state, and electromagnetic properties, which could provide useful information necessary to control the toxicity of NPs. Finally, the safety evaluation of nanotoxicity was addressed.

Từ khóa


Tài liệu tham khảo

Almeida A., 2016, Hormonal and organ‐specific dysfunction induced by the interaction between titanium dioxide nanoparticles and salicylic acid in male mice, Journal of Applied Toxicology, 27, 425

10.2217/nnm.11.79

Baek M., 2012, Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles, International Journal of Nanomedicine, 7, 3081

10.1016/j.biomaterials.2009.11.079

10.1371/journal.pone.0051995

Bao W., 2015, PLGA‐PLL‐PEG‐Tf‐based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway, Int J Nanomedicine, 10, 557

10.1155/2014/474081

10.1021/nn302502u

Bellusci M., 2014, Biodistribution and acute toxicity of a nanofluid containing manganese iron oxide nanoparticles produced by a mechanochemical process, International Journal of Nanomedicine, 9, 1919

10.2217/nnm.10.90

10.1016/j.jconrel.2011.06.039

10.1097/FJC.0b013e3181624aed

10.1116/1.2815690

Chen H., 2013, In Vivo Study of Spherical Gold Nanoparticles: Inflammatory Effects and Distribution in Mice, Plos One, 8, 10.1371/journal.pone.0058208

10.1016/j.taap.2008.03.022

10.1016/j.toxlet.2005.10.003

10.1007/s10967-007-0631-1

10.2217/nnm.14.186

10.1007/978-1-4939-1280-3_15

Choi S.‐J., 2014, Biokinetics of zinc oxide nanoparticles: Toxicokinetics, biological fates, and protein interaction, International Journal of Nanomedicine, 9, 261

10.1016/j.toxlet.2014.11.021

10.1002/jat.3323

Das Manandhar D. Krishna Y. Prasad T. Prajapati V. K. Basukala O. Aganja R. P. …Sundar S.(2014).Nanonization Increases the Antileishmanial Efficacy of Amphotericin B: An Ex Vivo Approach. InR.Adhikari &S.Thapa(Eds.) Infectious Diseases and Nanomedicine II(Vol. 808 pp. 77‐91). Springer India.

10.1186/1532-429X-15-7

10.1002/jat.2758

10.1016/j.addr.2011.09.001

10.1016/j.biomaterials.2011.05.035

10.1088/0957-4484/21/39/395101

10.1007/s11434-012-5187-y

10.2147/IJN.S8719

10.1186/1743-8977-11-30

10.3109/17435390.2016.1172678

10.1186/s12989-016-0133-9

10.1002/smll.201102648

10.1002/smll.200900626

10.1088/0957-4484/21/28/285103

10.1016/j.toxlet.2015.11.018

10.1039/c3tb20251h

10.1100/tsw.2011.44

10.1248/yakushi.14-00035-2

Jarrar B. M., 2014, Renal Histological Alterations Induced by 10 nm Gold Nanoparticles Toxicity in Relation with the Time of Exposure, Latin American Journal of Pharmacy, 33, 725

10.1039/C4MT00200H

10.1016/j.taap.2009.09.015

10.1007/s12031-012-9756-y

10.1186/1743-8977-7-20

Kim Y.‐R., 2014, Toxicity of colloidal silica nanoparticles administered orally for 90 days in rats, International Journal of Nanomedicine, 9, 67

Kim Y.‐R., 2014, Toxicity of 100 nm zinc oxide nanoparticles: A report of 90‐day repeated oral administration in Sprague Dawley rats, International Journal of Nanomedicine, 9, 109

Kim Y.‐R., 2014, Organization of research team for nano‐associated safety assessment in effort to study nanotoxicology of zinc oxide and silica nanoparticles, International Journal of Nanomedicine, 9, 3

10.1016/j.envint.2012.08.013

10.1016/j.jconrel.2014.11.005

10.2147/IJN.S17065

Korani M., 2013, Sub‐chronic Dermal Toxicity of Silver Nanoparticles in Guinea Pig: Special Emphasis to Heart, Bone and Kidney Toxicities, Iranian Journal of Pharmaceutical Research, 12, 511

10.1016/j.addr.2013.07.007

10.1080/08958370902942517

10.1016/j.biomaterials.2010.07.045

10.1002/smll.200801788

Lee J. A., 2014, Tissue distribution and excretion kinetics of orally administered silica nanoparticles in rats, International Journal of Nanomedicine, 9, 251

10.1016/j.nano.2014.10.002

10.1007/s11051-008-9369-0

10.1371/journal.pone.0024406

10.1166/jnn.2009.1320

10.1016/j.toxlet.2011.10.011

10.1080/15287390903486543

10.1007/s11095-009-9973-4

10.2147/IJN.S92278

10.1016/j.ejpb.2009.03.007

10.1021/nn402043c

10.3109/08958378.2011.553248

10.1016/j.ecoenv.2010.09.002

10.1039/c3nr02140h

10.1002/jat.2932

10.1007/s00204-014-1256-0

10.1016/j.toxlet.2016.11.014

10.1002/tox.22263

10.1186/s12989-016-0124-x

Ryu H. J., 2014, Zinc oxide nanoparticles: A 90‐day repeated‐dose dermal toxicity study in rats, International Journal of Nanomedicine, 9, 137

10.1007/978-1-4614-3055-1_5

10.1039/C1CS15188F

10.1016/j.ijpharm.2011.09.041

10.1186/1743-8977-10-15

10.1177/0748233715613224

10.1016/j.nano.2012.06.002

10.1007/s11095-014-1425-0

10.1093/toxsci/kfn246

10.1007/s11427-012-4404-x

10.1166/jnn.2011.3604

10.3109/17435390.2013.822114

10.2217/nnm-2016-0049

10.1042/BST0350527

Tiwari D. K., 2011, Bio‐distribution and toxicity assessment of intravenously injected anti‐HER2 antibody conjugated CdSe/ZnS quantum dots in Wistar rats, International Journal of Nanomedicine, 6, 463

10.1007/s12011-007-0028-6

10.1021/ar2003336

10.1007/s11051-008-9452-6

10.1007/s12011-017-0934-1

10.1080/10773525.2016.1278510

10.1016/j.toxlet.2008.10.001

10.1016/j.toxlet.2006.12.001

Wang Y., 2014, Effects of TiO2 nanoparticles on antioxidant function and element content of liver and kidney tissues in young and adult rats. Journal of Peking University, Health Sciences, 46, 395

10.1016/j.toxlet.2009.11.006

10.1265/jjh.66.628

10.3109/08958378.2013.871762

10.2217/nnm.09.5

10.1016/j.chemosphere.2013.01.094

10.1186/s12974-016-0529-3

10.1166/jnn.2014.9198

10.2147/IJN.S8428

10.7150/thno.7653